Home About Press Employ Contact Spyglass Advanced Search
HHMI Logo
HHMI News
HHMI News
Scientists & Research
Scientists & Research
Janelia Farm
Janelia Farm
Grants & Fellowships
Grants & Fellowships
Resources
Resources
  HHMI News
  Top Stories  
dashed line
Research News
dashed line

How the Snake Got Its Vertebraesmall arrow

dashed line

Mutant Mouse Mimics Human Bone Cancersmall arrow

dashed line

You've Gotta Have HAARTsmall arrow

dashed line

Moresmall arrow

dashed line
  Science Education News  
dashed line
  Institute News  
dashed line
  NewsSrch  
dashed line
  Noticias  

News Alert
Sign Up
Research News

June 22, 2001
Gene Therapy Restores Feeding Behavior to Starving Mice

Researchers have used gene therapy to rejuvenate feeding behavior in starving mice. The genetically engineered mice avoided eating because their brains contained a low level of dopamine.

The scientists’ experiments, which were reported in the June 2001 issue of the journal Neuron , provide new information about a region of the brain that helps integrate internal hunger signals and external sensory information about food to trigger feeding behavior.


“I was quite impressed by the fact that we could inject the virus once and rescue feeding behavior for the life of the animal.”
Mark S. Szczypka

A research team led by Richard D. Palmiter , a Howard Hughes Medical Institute investigator at the University of Washington, demonstrated that gene therapy restored dopamine production in specific areas of the brains of mutant mice. The mice, which were developed by Qun-Yong Zhou in Palmiter’s laboratory in the mid-1990s, lack tyrosine hydroxylase, an enzyme that is required to produce L-DOPA, a chemical precursor that is converted into the neurotransmitter dopamine. These mice lack the motivation to feed, and die of starvation a few weeks after birth, unless they are hand-fed or injected daily with L-DOPA. The gene therapy restored feeding behavior in the mice.

“These dopamine-deficient mice have many other behavioral deficits,” said Palmiter. “In addition to not eating adequately, they show no preference for sweets, they fail to build nests and they lack curiosity in novel environments. They are generally hypoactive, they are also slow to initiate movements and they have difficulty with coordination — a syndrome that resembles parkinsonism.”

According to Palmiter, researchers did not know which region of the brain was responsible for the impaired feeding behavior and other deficits noted in the mice. Palmiter and his colleagues suspected that dopamine-producing neurons in the mid-brain that send their axon processes to the striatum played a key role in integrating brain signals to produce specific behaviors. But they did not know which part of the striatum would be involved. The striatum is divided into two segments — the caudate putamen and the nucleus accumbens.

Mark S. Szczypka, a postdoctoral fellow in Palmiter’s laboratory, attempted to restore dopamine production in the caudate putamen and nucleus accumbens, by injecting harmless adeno-associated viruses carrying the genes for tyrosine hydroxylase and GTP cyclohydrolase I. The viruses were supplied by co-author Brian A. Donahue of Cell Genesys, Inc., of Foster City, California.

Surprisingly, viral injections restored feeding behavior only when the injections targeted the caudate putamen. Targeting the caudate putamen also revived the animals’ preference for palatable, high-fat foods and sugar water. “I would speculate that hunger signals are produced because these animals are starving most of the time,” said Palmiter. “Those signals are probably reaching the caudate putamen, where they would interact with sensory signals reflecting the sight and smell of food. Our guess, however, is that in the absence of dopamine, the caudate putamen can’t put those signals together to elicit food-seeking behavior.”

Injections into the nucleus accumbens did not improve feeding on normal rodent chow, but they did improve exploratory behavior and a preference for more palatable foods. However, the mice did not eat the palatable food long enough or in sufficient quantity to maintain weight. “Considerable research on drug addiction and the reward mechanisms in the brain had implicated the nucleus accumbens in processing reward-like behaviors,” said Szczypka. “We assumed that eating food was a rewarding behavior, so we were surprised that treatment of the nucleus accumbens did not work.”

Restoration of dopamine production in the caudate putamen also rejuvenated nest-building behavior. “Mice readily build nests when given nesting material,” said Palmiter. “But in the absence of dopamine, the mice never built nests. Since the treated mice resumed nest-building, we suspect that other motivated behaviors may also be rescued by treatment.”

Dopamine has many functions outside the caudate putamen, said Michelle Brot, a co-investigator on the study. Brot points out that “restoration of feeding by viral treatment of the caudate putamen provides a unique model for investigating the role of dopamine in other brain regions, such as its functions in the nucleus accumbens in mediating reward, and its role in the hippocampus in learning and memory.”

The motor coordination of the mice treated in either brain region did not appear to improve very much following gene therapy. The treated mice were still slow to initiate movement and had poor coordination. This indicated that other brain regions remained dopamine-deficient, said Palmiter.

Future studies will seek to define mechanisms by which dopamine facilitates feeding. In addition, the scientists will attempt to pinpoint the region that restores feeding and possibly dissociate it from nest-building behavior. They also plan to restore dopamine production to dopamine-producing neurons in the substantia nigra and the ventral tegmental area. They predict that this treatment will correct the motor deficits in these mice.

The rescue of feeding behavior in mice may offer insight into nutritional problems in Parkinson’s disease patients, said Palmiter. “It’s known that people with Parkinson’s have eating difficulties, which have been ascribed to difficulties in manipulating utensils, chewing and swallowing, as well as depression,” Palmiter said. “Our mouse studies suggest that there is an underlying motivational deficit in Parkinson’s disease, as well.”

Szczypka noted that viral gene therapy can be a very effective means of treating neurological and other genetic disorders. “I was quite impressed by the fact that we could inject the virus once and rescue feeding behavior for the life of the animal,” he said. “Admittedly, a mouse’s life is short relative to a person’s life, but still it’s an efficacious treatment with a great deal of potential.”

   

MORE HEADLINES

bullet icon

INSTITUTE NEWS

06.20.08 | 

HHMI Appoints Marian B. Carlson as Senior Scientific Officer

06.05.08 | 

Early Career Physician-Scientists Awarded $7.1 Million

06.05.08 | 

Students Awarded Research Grants
Noticias del HHMI Search News Archive

Download Story PDF

Requires Adobe Acrobat

Versión en españolsmall arrow

HHMI INVESTIGATOR

Richard D. Palmiter
Richard D. Palmiter
abstract:
Genetics of Mouse Behavior
 

Related Links

AT HHMI

bullet icon

Mapping the Brain's Food-Intake Circuitry
(03.29.01)

bullet icon

Chipping Away at Leptin's Effects
(04.15.00)

bullet icon

Fruit Fly Studies May Boost Understanding of Cocaine Addiction
(01.25.01)

bullet icon

Serotonin May Hold Key to Hyperactivity Disorder
(01.15.99)

bullet icon

Knockout Mice Reveal Mechanism of Dopamine Regulation
(02.15.96)

dashed line
 Back to Topto the top
HHMI Logo

Home | About HHMI | Press Room | Employment | Contact

© 2008 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | e-mail: webmaster@hhmi.org